Related Experiment Video
Updated: Jul 15, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Role of the oncogenic Raf-1 in orchestration of discrete nuclear factor-kappaB-activating pathways
1Laboratory of Virology, Lindsley F. Kimball Research Institute of the New York Blood Center, New York, NY 10021, USA.
Abstract:
Raf-1, a key kinase in the Ras signaling pathway, plays critical roles in cell differentiation, proliferation, and tumorigenesis. However, knowledge of the Raf-1 in inflammation is limited. Using an inducible oncogenic Raf-1, we show that the Raf-1 orchestrates the discrete NF-kappaB activating pathways. While the Raf-1 activation induces a modest IkappaB degradation by enhancing the basal IkappaB kinase activity, it contradictorily suppresses the proinflammatory cytokine inducible IkappaB kinase complex, leading to an inhibition of TNF-alpha- and IL-1beta-induced NF-kappaB activation. Despite considerable degrees of overlap, LPS signaling is not affected by Raf-1. By either conditionally reducing Raf-1 activity or completely disrupting the Raf-1 signaling by PD98059, a specific inhibitor of MEK1, the otherwise inhibited cytokine responses can be restored. Moreover, when the activity of Raf-1 is up-regulated during the cell cycle progression from the G(0) phase to the late G(1) phase, the enhanced Raf-1 activity suffices to shift the TNF-alpha response from the sensitive to the insensitive state. Together, these studies elucidate a mechanism by which signaling outputs are shaped by the intracellular Raf-1, thus explaining the "cellular context"-dependent cytokine response.
Insights
Raf-1 kinase regulates inflammation by differentially controlling NF-kappaB pathways. It suppresses pro-inflammatory cytokine responses while sparing LPS signaling, explaining context-dependent cytokine reactions.
Area of Science:
- Molecular Biology
- Cell Signaling
- Immunology
Background:
- Raf-1 is a key kinase in the Ras signaling pathway, crucial for cell differentiation, proliferation, and tumorigenesis.
- Its precise role in inflammatory processes remains incompletely understood.
Purpose of the Study:
- To elucidate the role of Raf-1 in orchestrating Nuclear Factor-kappaB (NF-kappaB) activation pathways during inflammation.
- To investigate how Raf-1 activity influences the cellular response to pro-inflammatory cytokines and lipopolysaccharide (LPS).
Main Methods:
- Utilized an inducible oncogenic Raf-1 model system.
- Assessed NF-kappaB activation by measuring IkappaB degradation and IkappaB kinase (IKK) activity.
- Employed PD98059, a specific inhibitor of MEK1, to disrupt Raf-1 signaling.
- Analyzed cytokine responses in different cell cycle phases.
Main Results:
- Raf-1 activation enhanced basal IKK activity, causing modest IkappaB degradation.
- Raf-1 suppressed inducible IKK complex activity, inhibiting NF-kappaB activation by TNF-alpha and IL-1beta.
- LPS-induced signaling remained unaffected by Raf-1 modulation.
- Inhibition of Raf-1 signaling restored suppressed cytokine responses.
- Increased Raf-1 activity during cell cycle progression rendered cells insensitive to TNF-alpha.
Conclusions:
- Raf-1 plays a dual role in NF-kappaB activation, enhancing basal activity while suppressing inducible responses to certain cytokines.
- Raf-1 signaling dictates context-dependent cytokine responses, influencing cellular sensitivity based on its activity levels and cell cycle status.
More Related Videos
Related Concept Videos
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

